Endovascular Treatment of Thoracic Aortic Disease

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Matthew Eagleton
Study ID
NCT00583817
Status
Enrolling By Invitation

Conditions

  • Aortic Arch; Aneurysm, Dissecting
  • Aortic Dissection
  • Ascending Aorta Aneurysm
  • Ascending Aortic Dissection
  • Dissecting, Aneurysm
  • Renal Artery Aneurysm
  • Superior Mesenteric Artery Aneurysm
  • Thoracic Aortic Aneurysms
  • Thoracoabdominal Aortic Aneurysm

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Endovascular stent-graft implantation — DEVICE
    Endovascular repair of aorta: Patient-specific F/BEVAR treatment

Study Details

The purpose of this study is to assess the role endovascular therapy to treat aortic disease involving the ascending aorta, the aortic arch, and the visceral segment of the aorta (or thoracoabdominal aorta)

Key Dates

Start date
Oct 25, 2018
Status verified
Apr 2026
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
170 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Ascending Aortic Arm
    Investigational endovascular stent-graft implantation to exclude aneurysm or repair dissection of the ascending aorta.
  • Experimental: Arch Branch Arm
    Investigational endovascular stent-graft implantation to exclude aneurysm or repair dissection of the aortic arch.
  • Experimental: Thoracoabdominal Aortic Arm
    Investigational endovascular stent-graft implantation to exclude thoracoabdominal aortic pathology including aortic aneurysms, renal artery aneurysms, and superior mesenteric artery aneurysms.

Primary Outcome Measure

All-cause mortality [ Time Frame: 5 years ]

Locations (2)

FacilityCityStateZIPSite coordinators
Brigham and Women's HospitalBostonMassachusetts02115-
Massachusetts General HospitalBostonMassachusetts02114-

Find similar trials in Boston, MA

Related Studies